Amplified sinus-P-wave reveals localization and extent of left atrial low-voltage substrate: implications for arrhythmia freedom following pulmonary vein isolation.

Atrial fibrillation Electrocardiogram Low voltage substrate P-wave Pulmonary vein isolation Recurrence Voltage mapping

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 31 05 2019
accepted: 18 10 2019
pubmed: 30 11 2019
medline: 29 6 2021
entrez: 30 11 2019
Statut: ppublish

Résumé

Presence of arrhythmogenic left atrial (LA) low-voltage substrate (LVS) is associated with reduced arthythmia freedom rates following pulmonary vein isolation (PVI) in persistent atrial fibrillation (AF). We hypothesized that LA-LVS modifies amplified sinus-P-wave (APW) characteristics, enabling identification of patients at risk for arrhythmia recurrences following PVI. Ninety-five patients with persistent AF underwent high-density (>1200 sites) voltage mapping in sinus rhythm. Left atrial low-voltage substrate (<0.5 and <1.0 mV) was quantified in a 10-segment LA model. Amplified sinus-P-wave-morphology and -duration were evaluated using digitized 12-lead electrocardiograms (40-80 mm/mV, 100-200 mm/s). 12-months arrhythmia freedom following circumferential PVI was assessed in 139 patients with persistent AF. Left atrial low-voltage substrate was most frequently (84%) found at the anteroseptal LA. Characteristic changes of APW were related to the localization and extent of LA-LVS. At an early stage, LA-LVS predominantly located to the LA-anteroseptum and was associated with APW-prolongation (≥150 ms). More extensive LA-LVS involved larger areas of LA-anteroseptum, leading to morphological changes of APW (biphasic positive-negative P-waves in inferior leads). Severe LA-LVS involved the LA-anteroseptum, roof and posterior LA, but spared the inferior LA, lateral LA, and LA appendage. In this advanced stage, widespread LVS at the posterior LA abolished the negative portion of P-wave in the inferior leads. The delayed activation of the lateral LA and LA appendage produced the late positive deflections in the anterolateral leads, resulting in the "late-terminal P"-pattern. Structured analysis of APW-duration and -morphology stratified patients to their individual extent of LA-LVS (Grade 1: mean LA-LVS 4.9 cm2 at <1.0 mV; Grade 2: 28.6 cm2; Grade 3: 42.3 cm2; P < 0.01). The diagnostic value of APW-duration for identification of LA-LVS was significantly superior to standard P-wave-amplification (c-statistic 0.945 vs. 0.647). Arrhythmia freedom following PVI differed significantly between APW-predicted grades of LA-LVS-severity [hazard ratio (HR) 2.38, 95% confidence interval (CI) 1.18-4.83; P = 0.015 for Grade 1 vs. Grade 2; HR 1.79, 95% CI 1.00-3.21, P = 0.049 for Grade 2 vs. Grade 3). Arrhythmia freedom 12 months after PVI was 77%, 53%, and 33% in Grades 1, 2 and 3, respectively. Localization and extent of LA-LVS modifies APW-morphology and -duration. Analysis of APW allows accurate prediction of LA-LVS and enables rapid and non-invasive estimation of arrhythmia freedom following PVI.

Identifiants

pubmed: 31782781
pii: 5647330
doi: 10.1093/europace/euz297
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-249

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Björn Müller-Edenborn (B)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Juan Chen (J)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Jürgen Allgeier (J)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Maxim Didenko (M)

Cardiovascular Surgery Department, Military Medical Academy Named After S.M. Kirov, Saint-Petersburg, Russia.
Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, The Netherlands.

Zoraida Moreno-Weidmann (Z)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Franz-Josef Neumann (FJ)

Department of Cardiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Bad Krozingen, Germany.

Heiko Lehrmann (H)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Reinhold Weber (R)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Thomas Arentz (T)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Amir Jadidi (A)

Department of Electrophysiology, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen Campus, Südring 15, 79189 Bad Krozingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH